Oscar Health (OSCR) Return on Capital Employed (2021 - 2026)

Oscar Health has reported Return on Capital Employed for 6 years, with the latest figure at 24.87% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 5655.0% year-over-year to 24.87%; the trailing twelve-month figure through Mar 2026 stood at 24.87% (down 5655.0% YoY), and the FY2025 full-year result was 55.02%, down 7953.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 24.87%, down from 6.02% in the prior quarter.
• The five-year high for Return on Capital Employed was 31.68% in Q1 2025, with the low at 33.24% in Q1 2024.
• Historically, Return on Capital Employed has averaged 6.92% across 5 years, with a median of 11.86% in 2024.
• Annual changes were most pronounced in 2025 — Return on Capital Employed soared 6492 bps — and 2026, when it plunged 5655 bps.
• Oscar Health's Return on Capital Employed stood at 18.5% in 2022, then sank by 74 bps to 32.13% in 2023, then surged by 132 bps to 10.35% in 2024, then sank by 42 bps to 6.02% in 2025, then plunged by 513 bps to 24.87% in 2026.
• The last three Return on Capital Employed figures came in at 24.87% (Q1 2026), 6.02% (Q4 2025), and 18.44% (Q3 2025), per Business Quant data.